Badrilla Ltd, founded in 2003, is an established life science company providing high quality products for the molecular cardiovascular researcher located within major pharmaceutical, biotech, and academic establishments worldwide. Badrilla assists researchers in combining its expertise of meticulous organic and protein chemistry with its knowledge of the post-translational modification of the proteins that coordinate cardiac excitation-contraction coupling, cardiac arrhythmia and hypertrophy, and the maladaptive response leading to heart failure, in order to produce research tools of the highest integrity and broadest application.Over the past ten years Badrilla products have helped to underpin key discoveries in cardiac biochemistry and the Company has garnered a wealth of published data from respected scientists worldwide. Working in concert with its Clients, Badrilla continues to develop new products and services which will both expand and strengthen its focussed position to mutual benefit.
Badrilla aims to develop exceptional reagents to enable new discoveries in cardiovascular science for the benefit of researchers, research sponsors and cardiac patients.
The focus and expertise of Badrilla lies in dynamic post-translational modification of the proteins that coordinate cardiac excitation-contraction coupling, cardiac arrhythmias, cardiac hypertrophy and the maladaptive response leading to heart failure. Working with leading cardiac researchers we are able to build and validate new reagents of value to the whole field.
We welcome the opportunity to discuss new and leading programmes of collaborative research with you, where we can play a minor or major role. Please email firstname.lastname@example.org in the first instance.
Excellent research tools are made by individual research teams all the time. We are interested in helping share these tools with the whole cardiovascular research community, and generate some welcome revenue for your laboratory. This can be achieved by licensing reagents to Badrilla for the commercial distribution worldwide. We are specifically interested in the following types of reagent:
Please email email@example.com to start the discussion.